DARPA is offering this grant to solicit research proposals aimed at advancing diagnostic capabilities. This initiative focuses on developing sophisticated nucleic acid and protein tests and automating the analysis of fresh or stored biospecimens in clinical settings. The goal is to integrate these innovations into highly multiplexed platforms, designed for rapid reconfigurability to address evolving medical challenges and emerging needs. This grant is for the purpose of creating autonomous, point-of-care diagnostic systems that enable Diagnostics on Demand, supporting enhanced prevention and therapeutic interventions. It seeks to fund innovative solutions that will provide swift, adaptable, and comprehensive diagnostic insights, ultimately transforming the landscape of clinical diagnostics for national security and public health.
Opportunity ID: 78413
General Information
Document Type: | Grants Notice |
Funding Opportunity Number: | DARPA-BAA-11-38 |
Funding Opportunity Title: | Autonomous Diagnostics to Enable Prevention and Therapeutics: Diagnostics on Demand � Point of Care (ADEPT: DxOD -PoC) |
Opportunity Category: | Discretionary |
Opportunity Category Explanation: | – |
Funding Instrument Type: | Cooperative Agreement Grant Other Procurement Contract |
Category of Funding Activity: | Science and Technology and other Research and Development |
Category Explanation: | – |
Expected Number of Awards: | – |
Assistance Listings: | 12.910 — Research and Technology Development |
Cost Sharing or Matching Requirement: | No |
Version: | Synopsis 2 |
Posted Date: | Mar 14, 2011 |
Last Updated Date: | May 11, 2011 |
Original Closing Date for Applications: | May 17, 2011 |
Current Closing Date for Applications: | May 17, 2011 |
Archive Date: | Jul 18, 2011 |
Estimated Total Program Funding: | – |
Award Ceiling: | – |
Award Floor: | – |
Eligibility
Eligible Applicants: | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” |
Additional Information on Eligibility: | – |
Additional Information
Agency Name: | DARPA – Defense Sciences Office |
Description: | DARPA is soliciting research proposals to develop advanced nucleic acid and protein tests, automate analysis of fresh and/or stored biospecimens in clinical settings integrated into highly multiplexed platforms that are rapidly reconfigurable for emerging needs.
See attached DARPA-BAA-11-38. |
Link to Additional Information: | DARPA-BAA-11-38 Solitication Address |
Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
BAA COORDINATOR
Email:DARPA-BAA-11-38@darpr.mil |
Version History
Version | Modification Description | Updated Date |
---|---|---|
See attached Modification 1. | May 11, 2011 | |
May 11, 2011 |
DISPLAYING: Synopsis 2
General Information
Document Type: | Grants Notice |
Funding Opportunity Number: | DARPA-BAA-11-38 |
Funding Opportunity Title: | Autonomous Diagnostics to Enable Prevention and Therapeutics: Diagnostics on Demand � Point of Care (ADEPT: DxOD -PoC) |
Opportunity Category: | Discretionary |
Opportunity Category Explanation: | – |
Funding Instrument Type: | Cooperative Agreement Grant Other Procurement Contract |
Category of Funding Activity: | Science and Technology and other Research and Development |
Category Explanation: | – |
Expected Number of Awards: | – |
Assistance Listings: | 12.910 — Research and Technology Development |
Cost Sharing or Matching Requirement: | No |
Version: | Synopsis 2 |
Posted Date: | Mar 14, 2011 |
Last Updated Date: | May 11, 2011 |
Original Closing Date for Applications: | May 17, 2011 |
Current Closing Date for Applications: | May 17, 2011 |
Archive Date: | Jul 18, 2011 |
Estimated Total Program Funding: | – |
Award Ceiling: | – |
Award Floor: | – |
Eligibility
Eligible Applicants: | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” |
Additional Information on Eligibility: | – |
Additional Information
Agency Name: | DARPA – Defense Sciences Office |
Description: | DARPA is soliciting research proposals to develop advanced nucleic acid and protein tests, automate analysis of fresh and/or stored biospecimens in clinical settings integrated into highly multiplexed platforms that are rapidly reconfigurable for emerging needs.
See attached DARPA-BAA-11-38. |
Link to Additional Information: | DARPA-BAA-11-38 Solitication Address |
Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
BAA COORDINATOR
Email:DARPA-BAA-11-38@darpr.mil |
DISPLAYING: Synopsis 1
General Information
Document Type: | Grants Notice |
Funding Opportunity Number: | DARPA-BAA-11-38 |
Funding Opportunity Title: | Autonomous Diagnostics to Enable Prevention and Therapeutics: Diagnostics on Demand – Point of Care (ADEPT: DxOD -PoC) |
Opportunity Category: | Discretionary |
Opportunity Category Explanation: | – |
Funding Instrument Type: | Cooperative Agreement Grant Other Procurement Contract |
Category of Funding Activity: | Science and Technology and other Research and Development |
Category Explanation: | – |
Expected Number of Awards: | – |
Assistance Listings: | 12.910 — Research and Technology Development |
Cost Sharing or Matching Requirement: | No |
Version: | Synopsis 1 |
Posted Date: | May 11, 2011 |
Last Updated Date: | – |
Original Closing Date for Applications: | – |
Current Closing Date for Applications: | May 17, 2011 |
Archive Date: | Jul 18, 2011 |
Estimated Total Program Funding: | – |
Award Ceiling: | – |
Award Floor: | – |
Eligibility
Eligible Applicants: | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” |
Additional Information on Eligibility: | – |
Additional Information
Agency Name: | DARPA – Defense Sciences Office |
Description: | DARPA is soliciting research proposals to develop advanced nucleic acid and protein tests, automate analysis of fresh and/or stored biospecimens in clinical settings integrated into highly multiplexed platforms that are rapidly reconfigurable for emerging needs.
See attached DARPA-BAA-11-38. |
Link to Additional Information: | DARPA-BAA-11-38 Solitication Address |
Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
BAA COORDINATOR
Email:DARPA-BAA-11-38@darpr.mil |
Related Documents
Folder 78413 Full Announcement-1 -> darpa-baa-11-38 dxod-poc.pdf
Folder 78413 Revised Full Announcement-1 -> darpa-baa-11-38 modification 1.pdf
Packages
Agency Contact Information: | BAA COORDINATOR Email: DARPA-BAA-11-38@darpr.mil |
Who Can Apply: | Organization Applicants |
Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
---|---|---|---|---|---|---|
12.910 | PKG00039910 | Mar 14, 2011 | May 17, 2011 | View |
Package 1
Mandatory forms
78413 RR_SF424-1.1.pdf
Optional forms
78413 RR_FedNonFedBudget-1.1.pdf
78413 RR_FedNonFed_SubawardBudget-1.2.pdf
78413 RR_OtherProjectInfo-1.1.pdf
78413 RR_Budget-1.1.pdf
78413 RR_KeyPersonExpanded-1.1.pdf
78413 RR_PerformanceSite-1.1.pdf
78413 RR_SubawardBudget-1.2.pdf